Drug Identity
Active Ingredient
Erlotinib
Chemical Class
Quinazolinamine
Pharmacological Group
on the basis of mechanism of action
ATC Code
L01EB02
Status
Essential Medicine
What is Erlonib?
Uses
Erlotinib is a type of targeted therapy used to treat cancer. Erlotinib is a tyrosine kinase inhibitor that works by blocking the kinase ...
How It Works
Chemical Class
Quinazolinamine
Pharmacological Group
on the basis of mechanism of action
belongs to Quinazolinamine. It belongs to Epidermal Growth Factor Receptor pharmacological group on the basis of mechanism of action. The Molecular Weight of Erlotinib is 429.90. It is strongly acidic drug and Its pKa is 5.42.
How to Take It
1
Adult · oral
100 mg — 24 hourly
For non-small cell PANCREATIC cancer, should be taken at least one hour before or two hours after the ingestion of food.
2
Adult · PO
150 mg — 24 hourly
For non-small cell LUNG cancer, should be taken at least one hour before or two hours after the ingestion of food.
3
Adult
Scraped Dose
Take erlotinib tablets exactly as prescribed by your healthcare provider. Take erlotinib once daily. Take erlotinib on an empty stomach, one hour before food or two hours after food.
Safety Alerts
Do not take erlotinib if you are allergic to erlotinib or any of the ingredients in it
See below for a complete list of ingredients
Important Warnings
Erlotinib can cause serious side effects, including Lung problems called interstitial lung disease events
Erlotinib has been shown to cause lung problems, including death
Symptoms of lung problems may include shortness of breath, cough, and fever
Erlotinib may need to be stopped if you have any of these symptoms
Liver and kidney problems
Erlotinib has been shown to cause severe kidney and liver problems, including death
Some people had their kidneys and liver stop working
Let your healthcare provider know if you have a history of liver or kidney disease
Side Effects
Erlotinib can cause serious side effects including: See "Important information" above. Erlotinib can cause skinhair and nail problems: While taking erlotinib a rash could appear or get worse if the skin is exposed to the sun. You may want to use alcohol-free lotions and sunscreens or avoid being out in the sun. Your skin and nails may get darker while taking erlotinib. You may also have dry skin that may or may not crack. This most often happens with rash. You may get more hairy and develop brittle or loose nails. The most common side effects of erlotinib in patients with NSCLC who had not received previous chemotherapy are: diarrhea weakness rash cough shortness of breath loss of appetite (not wanting to eat) The most common side effects of erlotinib in patients with NSCLC receiving it as maintenance2nd or 3rd line therapy are: rash diarrhea The most common side effects of erlotinib in patients with pancreatic cancer are: fatigue (feeling very tired) rash nausea loss of appetite diarrhea These are not all of the possible side effects with erlotinib. Call your doctor for medical advice about side effects. Talk to your doctor about any side effects that bother you or do not go away. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
Drug Interactions
Erlotinib can interact with a number of other medications. You may need to adjust the dose or timing of erlotinib or your other medications. Tell your healthcare provider about all the medicines you take
including prescription and over-the-counter medicines
vitamins
and herbal supplements. Talk to your healthcare provider before taking any new medicines or supplements. Do not eat grapefruit or drink grapefruit juice before talking with your healthcare provider.
Storage
Store Below 30°C.
Price Intelligence
Rs 49,322.87
DRAP approved maximum price · per pack of 30 · approved 24 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 30Rs 49,322.87
Should you consider an alternative?
Other options containing Erlotinib, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Tarsinib
150mg
Rs 53,418.29
No DRAP alertsMARTIN DOW
Erlocip
150mg
Rs 44,704.11 ceiling
No DRAP alertsAJ Mirza Pharma Pvt Ltd
Erlotirel
150mg
Rs 41,272.2 ceiling
Helix Pharma (Pvt)., Ltd.
Tarceva
150mg
Rs 270,127.02 ceiling
Ali Gohar & Company (Private) Limited
Tinlo
150mg
Rs 48,289.76 ceiling
No DRAP alertsLab Diagnostic Systems (SMC) Pvt. Ltd.
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
300
brands
261
molecules
1
alerts